s kind in this setting but says the results in terms of effectiveness are years away. It will take a while before there is enough follow-up to be able to have enough recurrences to make a statement. He is optimistic about the efficacy of exemestane and says Our goal is to increase the number of patients who are cured from breast cancer by preventing a recurrence. Anything that prevents recurre